Congress moves to break up insurer-provider ownership to restore healthcare competition
S. 2836 — POP Act · Filed by Jeff Merkley (D-OR) · 2 cosponsors · Introduced Sep 17, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prohibits any company or person from simultaneously owning a health insurance company and a healthcare provider (such as a doctor's office or clinic) that serves Medicare patients. Companies already in violation have 2 years to divest one or the other; new violations have 1 year. The bill empowers the FTC, DOJ, state attorneys general, and HHS to sue for enforcement, and requires Medicare Advantage and Part D plans to certify compliance or lose federal payment.
Why we flagged it
The bill's core mechanism is a structural prohibition on vertical integration between insurers and providers—a classic antitrust remedy designed to eliminate conflicts of interest and restore competitive market conditions in healthcare.
What the text implies
- Divestment may trigger significant M&A activity and market consolidation as companies choose which business line to retain, potentially creating short-term disruption in healthcare delivery.
- The bill's definition of 'applicable provider' excludes hospitals, critical access hospitals, rural emergency hospitals, DME suppliers, and pharmacies—leaving those vertical integrations untouched and potentially creating competitive asymmetries.
- Revenue disgorgement provisions may create a new federal fund for healthcare in underserved communities, but the mechanism for distribution and use is delegated to FTC rulemaking, leaving implementation details opaque.
- Medicare Advantage and Part D plans face certification requirements and false-claims liability, which may increase compliance costs and administrative burden on plans, potentially passed to beneficiaries through higher premiums.
- The bill does not address existing vertical integration in other healthcare sectors (e.g., pharmacy benefit managers owning pharmacies, hospital systems owning physician practices), creating potential regulatory arbitrage.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill addresses a structural conflict of interest where insurers owning providers can steer patients to their own facilities, limit care options, and suppress competition on price and quality. Ordinary citizens gain more transparent choice, lower incentives for unnecessary care, and stronger competitive pressure on healthcare costs. The enforcement mechanism is clear and the divestment timeline is reasonable.
Who stands to gain
- independent healthcare providers and physician practices
- standalone health insurance companies without provider networks
- healthcare consumers through reduced conflicts of interest and lower prices
Named in the bill
Federal Trade Commission (FTC), Department of Justice Antitrust Division, HHS Office of Inspector General, State Attorneys General, Medicare Advantage organizations, Medicare Part D plans, Health insurance issuers, Healthcare providers, Management services organizations, Johnson & Johnson, Bristol Myers Squibb, AIG — and 2 more
Where it stands
2 cosponsors: 2 Democrats.
- Sep 17, 2025 — Introduced · Congress.gov: “Introduced in Senate”
- Sep 17, 2025 — Referred to Senate Committee on the Judiciary · Congress.gov: “Read twice and referred to the Committee on the Judiciary”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
3 lobbying clients named this bill on 3 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $21,550,000 in lobbying spend. A filing names 24 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 61% of bills with at least one filing.
Jeff Merkley, the sponsor, reported $514,925 in PAC receipts in the 2026 cycle.
- Chamber of Commerce of the U.S.A. — $17,960,000 on 1 filing
- CVS Health (and Subsidiaries) — $3,570,000 on 1 filing
- Center for Health and Democracy — $20,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (8,848 characters) on Aug 18, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress moves to break up insurer-provider ownership to restore healthcare competition” QuorumCivic. https://share.quorumcivic.app/bill/119/s2836 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.